India: Religare Asset sale has nothing to do with Ranbaxy case, says Sunil Godhwani

India: Religare Asset sale has nothing to do with Ranbaxy case, says Sunil Godhwani

Visual from Religare website

Daiichi SankyoRanbaxy LaboratoriesReligare Enterprises Ltd

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

Read more from India

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.